(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that the Department of Anesthesiology at the Lausanne University Hospital (CHUV), one of Switzerland’s premier academic institutions, has chosen to make the Masimo W1™ advanced health tracking watch a key part of its pre-surgical patient assessm…
Blog Posts
LG’S CUTTING-EDGE WASHING MACHINES AND DRYERS FOR UNPARALLELED CLEANING RESULTS
Experience an Unmatched Cleaning Performance and Convenience with LG’s Best Washing Machines and Dryers
LG Electronics (LG) takes immense pride in presenting its best-in-class washing machines and dryers, setting new standards for superior cleaning performance. With a relentless commitment …
BYD Unleashes FANG CHENG BAO, A New Brand that Specializes in Professional and Personalized Identities
(BUSINESS WIRE) -- On June 9, BYD, the world’s leading manufacturer of new energy vehicles, officially announced its new sub-brand FANG CHENG BAO. The brand, as the fifth in the row of the BYD brand matrix, will meet the increasingly personalized needs of consumers by offering a series of unique and…
Mega Refining and Petrochemical Plant Selects Hytera as Provider of Professional Communications System
(BUSINESS WIRE) -- Hytera, a global leading provider of professional communication technologies and solutions, has been selected as the supplier of professional communications solution for the Yulong Island Refining and Petrochemical Integration Project in Shandong Province, China. Hytera won this p…
SES Space & Defense Delivers Satellite Connectivity to AWS Modular Data Center for the U.S. Department of Defense
SES Space & Defense to provide Medium Earth Orbit (MEO) and Geostationary Orbit (GEO) services for field-deployed AWS Modular Data Center units and one-hop connectivity to AWS Regions
(BUSINESS WIRE)--SES Space & Defense, a wholly-owned subsidiary of SES, today announced the availability of…
Verisign Reports Internet Has 354.0 Million Domain Name Registrations at the End of the First Quarter of 2023
RESTON, Va. - Friday, 09. June 2023 AETOSWire Print
(BUSINESS WIRE) -- VeriSign, Inc. (NASDAQ: VRSN), a global provider of domain name registry services and internet infrastructure, today announced that the first quarter of 2023 closed with 354.0 million domain name registrations across all top…
Cirium and Aireon Extend Partnership to Offer Live and Historical Aircraft Positional Analytics
LONDON - Thursday, 08. June 2023 AETOSWire
Cirium has blended its industry-leading schedule, fleet, flight status, weather and emissions data with Aireon’s live satellite-based aircraft tracking data for next generation positional analytics and AI
Bringing together these disparate datasets pro…
Parse Biosciences Launches CRISPR Detect
New product bolsters growing single cell portfolio
(BUSINESS WIRE) -- Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, announced today the launch of CRISPR Detect, enabling single cell pooled CRISPR screens at unprecedented scale.
Bulk po…
Parse Biosciences Launches CRISPR Detect
New product bolsters growing single cell portfolio
(BUSINESS WIRE) -- Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, announced today the launch of CRISPR Detect, enabling single cell pooled CRISPR screens at unprecedented scale.
Bulk pooled C…
Parse Biosciences Launches CRISPR Detect
New product bolsters growing single cell portfolio
(BUSINESS WIRE) -- Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, announced today the launch of CRISPR Detect, enabling single cell pooled CRISPR screens at unprecedented scale.
Bulk pooled C…
Blog Posts
Lausanne University Hospital (CHUV) Anesthesiology Department Adopts Masimo W1™ for Use in Preoperative Patient Assessment
(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that the Department of Anesthesiology at the Lausanne University Hospital (CHUV), one of Switzerland’s premier academic institutions, has chosen to make the Masimo W1™ advanced health tracking watch a key part of its pre-surgical patient assessm…
LG’S CUTTING-EDGE WASHING MACHINES AND DRYERS FOR UNPARALLELED CLEANING RESULTS
Experience an Unmatched Cleaning Performance and Convenience with LG’s Best Washing Machines and Dryers
LG Electronics (LG) takes immense pride in presenting its best-in-class washing machines and dryers, setting new standards for superior cleaning performance. With a relentless commitment …
BYD Unleashes FANG CHENG BAO, A New Brand that Specializes in Professional and Personalized Identities
(BUSINESS WIRE) -- On June 9, BYD, the world’s leading manufacturer of new energy vehicles, officially announced its new sub-brand FANG CHENG BAO. The brand, as the fifth in the row of the BYD brand matrix, will meet the increasingly personalized needs of consumers by offering a series of unique and…
Mega Refining and Petrochemical Plant Selects Hytera as Provider of Professional Communications System
(BUSINESS WIRE) -- Hytera, a global leading provider of professional communication technologies and solutions, has been selected as the supplier of professional communications solution for the Yulong Island Refining and Petrochemical Integration Project in Shandong Province, China. Hytera won this p…
SES Space & Defense Delivers Satellite Connectivity to AWS Modular Data Center for the U.S. Department of Defense
SES Space & Defense to provide Medium Earth Orbit (MEO) and Geostationary Orbit (GEO) services for field-deployed AWS Modular Data Center units and one-hop connectivity to AWS Regions
(BUSINESS WIRE)--SES Space & Defense, a wholly-owned subsidiary of SES, today announced the availability of…
Verisign Reports Internet Has 354.0 Million Domain Name Registrations at the End of the First Quarter of 2023
RESTON, Va. - Friday, 09. June 2023 AETOSWire Print
(BUSINESS WIRE) -- VeriSign, Inc. (NASDAQ: VRSN), a global provider of domain name registry services and internet infrastructure, today announced that the first quarter of 2023 closed with 354.0 million domain name registrations across all top…
Cirium and Aireon Extend Partnership to Offer Live and Historical Aircraft Positional Analytics
LONDON - Thursday, 08. June 2023 AETOSWire
Cirium has blended its industry-leading schedule, fleet, flight status, weather and emissions data with Aireon’s live satellite-based aircraft tracking data for next generation positional analytics and AI
Bringing together these disparate datasets pro…
Parse Biosciences Launches CRISPR Detect
New product bolsters growing single cell portfolio
(BUSINESS WIRE) -- Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, announced today the launch of CRISPR Detect, enabling single cell pooled CRISPR screens at unprecedented scale.
Bulk po…
Parse Biosciences Launches CRISPR Detect
New product bolsters growing single cell portfolio
(BUSINESS WIRE) -- Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, announced today the launch of CRISPR Detect, enabling single cell pooled CRISPR screens at unprecedented scale.
Bulk pooled C…
Parse Biosciences Launches CRISPR Detect
New product bolsters growing single cell portfolio
(BUSINESS WIRE) -- Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, announced today the launch of CRISPR Detect, enabling single cell pooled CRISPR screens at unprecedented scale.
Bulk pooled C…
Blog Component
Lausanne University Hospital (CHUV) Anesthesiology Department Adopts Masimo W1™ for Use in Preoperative Patient Assessment
(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that the Department of Anesthesiology at the Lausanne University Hospital (CHUV), one of Switzerland’s premier academic institutions, has chosen to make the Masimo W1™ advanced health tracking watch a key part of its pre-surgical patient assessment research program. This initiative, led by Professor Patrick Schoettker, Head of Anesthesiology at CHUV and a renowned expert in airway management, wireless monitoring, and the digital transformation of healthcare, is designed to help better inform anesthesiologists and surgical teams about their patients’ physiological status prior to surgery, with the ultimate goal of improving patient outcomes. Masimo W1, which offers accurate, continuous measurements of key physiological parameters, is available in Europe as a medical device that integrates with the Masimo SafetyNet® remote patient management platform.
Joe Kiani, Founder and CEO of Masimo, said, “We are excited to deepen our relationship with anesthesiologists at the CHUV and to help them leverage Masimo W1’s health tracking capabilities to help perioperative teams establish more insightful baseline physiological data about their patients. The baseline data can then allow clinicians to know what is normal and abnormal for each patient they care for in the hospital. Also, with Masimo W1, they can remotely monitor the patient post surgery at home when appropriate and reduce how long the patient remains in the hospital. We appreciate Dr. Schoettker and his team for recognizing the role that our technology can play in helping his department and the CHUV provide even better care for patients undergoing surgery, and we look forward to seeing Masimo W1 make a true difference in the lives of their patients.”
CHUV’s preoperative patient assessment program was launched in 2022, with the goal of using innovative technologies to identify areas of health and behavior improvements for each individual patient. Using multimodal prehabilitation, the team aims to address the physical, nutritional, and psychological needs of colorectal surgical patients. Aggregating data related to patients’ demographics, vital signs and behavior optimization will allow the team to offer more personalized management before, during, and after anesthesia and surgery. Starting later this year, as part of this program, patients scheduled for elective surgery will be provided with Masimo W1 watches two weeks in advance to help establish their baseline vital signs data, which will be relayed to clinicians during the preoperative anesthesia visit at the CHUV. Using the Masimo SafetyNet dashboard, perioperative teams will be able to use this data to develop a more nuanced and complete physiological profile of patients prior to surgery, allowing them to make more informed care decisions.
Prof. Schoettker commented, “We are looking forward to aggregating as much patient data as possible to better understand how each individual can benefit from a tailored approach. The time of ‘one size fits all’ anesthesia is over and personalized patient management is on the rise. While our mentors have helped make the operating room the safest place for the patient, with the highest density of highly qualified specialists per patient, our mission is now to offer that same level of quality and safety before and after any surgical procedure.”
Masimo W1 for use in medical applications is pending FDA clearance in the U.S.
@Masimo | #Masimo
About Masimo
Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and automation and connectivity solutions. In addition, Masimo Consumer Audio is home to eight legendary audio brands, including Bowers & Wilkins, Denon, Marantz, and Polk Audio. Our mission is to improve life, improve patient outcomes, and reduce the cost of care. Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry, introduced in 1995, has been shown in over 100 independent and objective studies to outperform other pulse oximetry technologies.1 Masimo SET® has also been shown to help clinicians reduce severe retinopathy of prematurity in neonates,2 improve CCHD screening in newborns3 and, when used for continuous monitoring with Masimo Patient SafetyNet™ in post-surgical wards, reduce rapid response team activations, ICU transfers, and costs.4-7 Masimo SET® is estimated to be used on more than 200 million patients in leading hospitals and other healthcare settings around the world,8 and is the primary pulse oximetry at 9 of the top 10 hospitals as ranked in the 2022-23 U.S. News and World Report Best Hospitals Honor Roll.9 In 2005, Masimo introduced rainbow® Pulse CO-Oximetry technology, allowing noninvasive and continuous monitoring of blood constituents that previously could only be measured invasively, including total hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), Pleth Variability Index (PVi®), RPVi™ (rainbow® PVi), and Oxygen Reserve Index (ORi™). In 2013, Masimo introduced the Root® Patient Monitoring and Connectivity Platform, built from the ground up to be as flexible and expandable as possible to facilitate the addition of other Masimo and third-party monitoring technologies; key Masimo additions include Next Generation SedLine® Brain Function Monitoring, O3® Regional Oximetry, and ISA™ Capnography with NomoLine® sampling lines. Masimo’s family of continuous and spot-check monitoring Pulse CO-Oximeters® includes devices designed for use in a variety of clinical and non-clinical scenarios, including tetherless, wearable technology, such as Radius-7®, Radius PPG®, and Radius VSM™, portable devices like Rad-67®, fingertip pulse oximeters like MightySat® Rx, and devices available for use both in the hospital and at home, such as Rad-97®. Masimo hospital and home automation and connectivity solutions are centered around the Masimo Hospital Automation™ platform, and include Iris® Gateway, iSirona™, Patient SafetyNet, Replica®, Halo ION®, UniView®, UniView :60™, and Masimo SafetyNet®. Its growing portfolio of health and wellness solutions includes Radius Tº® and the Masimo W1™ watch. Additional information about Masimo and its products may be found at www.masimo.com. Published clinical studies on Masimo products can be found at www.masimo.com/evidence/featured-studies/feature/.
ORi, RPVi, and Radius VSM have not received FDA 510(k) clearance and are not available for sale in the United States. The use of the trademark Patient SafetyNet is under license from University HealthSystem Consortium.
References
- Published clinical studies on pulse oximetry and the benefits of Masimo SET® can be found on our website at http://www.masimo.com. Comparative studies include independent and objective studies which are comprised of abstracts presented at scientific meetings and peer-reviewed journal articles.
- Castillo A et al. Prevention of Retinopathy of Prematurity in Preterm Infants through Changes in Clinical Practice and SpO2 Technology. Acta Paediatr. 2011 Feb;100(2):188-92.
- de-Wahl Granelli A et al. Impact of pulse oximetry screening on the detection of duct dependent congenital heart disease: a Swedish prospective screening study in 39,821 newborns. BMJ. 2009;Jan 8;338.
- Taenzer A et al. Impact of pulse oximetry surveillance on rescue events and intensive care unit transfers: a before-and-after concurrence study. Anesthesiology. 2010:112(2):282-287.
- Taenzer A et al. Postoperative Monitoring – The Dartmouth Experience. Anesthesia Patient Safety Foundation Newsletter. Spring-Summer 2012.
- McGrath S et al. Surveillance Monitoring Management for General Care Units: Strategy, Design, and Implementation. The Joint Commission Journal on Quality and Patient Safety. 2016 Jul;42(7):293-302.
- McGrath S et al. Inpatient Respiratory Arrest Associated With Sedative and Analgesic Medications: Impact of Continuous Monitoring on Patient Mortality and Severe Morbidity. J Patient Saf. 2020 14 Mar. DOI: 10.1097/PTS.0000000000000696.
- Estimate: Masimo data on file.
- http://health.usnews.com/health-care/best-hospitals/articles/best-hospitals-honor-roll-and-overview.
Forward-Looking Statements
This press release includes forward-looking statements as defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, in connection with the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, among others, statements regarding the potential effectiveness of Masimo W1™ and Masimo SafetyNet®, as well as the adoption of Masimo W1 by CHUV. These forward-looking statements are based on current expectations about future events affecting us and are subject to risks and uncertainties, all of which are difficult to predict and many of which are beyond our control and could cause our actual results to differ materially and adversely from those expressed in our forward-looking statements as a result of various risk factors, including, but not limited to: risks related to our assumptions regarding the repeatability of clinical results; risks related to our belief that Masimo's unique noninvasive measurement technologies, including Masimo W1 and Masimo SafetyNet, contribute to positive clinical outcomes and patient safety; risks related to our belief that Masimo noninvasive medical breakthroughs provide cost-effective solutions and unique advantages; risks that CHUV fails to realize the expected benefits of Masimo W1 or that CHUV fails to provide Masimo W1 to patients later this year in the manner described in this press release; risks related to COVID-19; as well as other factors discussed in the "Risk Factors" section of our most recent reports filed with the Securities and Exchange Commission ("SEC"), which may be obtained for free at the SEC's website at www.sec.gov. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we do not know whether our expectations will prove correct. All forward-looking statements included in this press release are expressly qualified in their entirety by the foregoing cautionary statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. We do not undertake any obligation to update, amend or clarify these statements or the "Risk Factors" contained in our most recent reports filed with the SEC, whether as a result of new information, future events or otherwise, except as may be required under the applicable securities laws.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230608005480/en/
Permalink
https://www.aetoswire.com/en/news/53417163en
Contacts
Media Contact:
Masimo
Evan Lamb
949-396-3376
elamb@masimo.com
LG’S CUTTING-EDGE WASHING MACHINES AND DRYERS FOR UNPARALLELED CLEANING RESULTS
Experience an Unmatched Cleaning Performance and Convenience with LG’s Best Washing Machines and Dryers
LG Electronics (LG) takes immense pride in presenting its best-in-class washing machines and dryers, setting new standards for superior cleaning performance. With a relentless commitment to innovation, LG has developed these appliances to deliver unparalleled results that go beyond ordinary laundry care. Whether you opt for a front-load or top-load washing machine, LG ensures that your clothes receive the utmost care and attention, resulting in garments that look impeccably clean and fresh.
Exceptional Allergy Care with LG Steam™ Washing Machine
LG takes well-being into account. Introducing the LG Steam™ washing machine, equipped with advanced technology to eliminate invisible allergens that can trigger allergies or respiratory problems. Experience 99.9% allergy care, as the steam effectively removes allergens, including dust mites, ensuring a cleaner and healthier laundry cycle.
For parents seeking the best care for their little ones, LG presents Baby Steam Care. This innovative feature provides a deep clean for your baby's clothes. By pre-treating them with the intense heat of steam prior to washing, Baby Steam Care guarantees the removal of stains and dirt, ensuring your baby's garments are fresh, hygienic, and ready to wear.
Furthermore, the LG Steam™ Washing Machine is built with durability and longevity in mind. With its reliable construction and high-quality components, this appliance is designed to withstand regular use and deliver consistent results for years to come.
With the LG Steam™ Washing Machine, you can achieve not only spotlessly clean clothes but also peace of mind knowing that your laundry is thoroughly sanitized and free from allergens.
Intelligent Care and Control
LG 2023 VIVACE 11kg Washing Machine is equipped with AI DD™ that enhances fabric protection during laundry by utilizing advanced technology and accumulated washing experience data. It intelligently detects the weight and softness of the fabric, enabling it to select the most suitable washing motions automatically. This optimized washing motion ensures the utmost care for your laundry. Additionally, AI DD™ offers a larger drum capacity within the same space, providing you with more room for your laundry. In terms of design, AI DD™ features a more elegant and visually appealing appearance.
Through the user-friendly SmartThinQ™ app, you can tap into a range of smart features that elevate your laundry experience. Keep a close eye on energy consumption, enabling you to make informed decisions and optimize your energy usage for both cost savings and a more sustainable lifestyle.
Additionally, the LG Steam™ Washing Machine's SmartThinQ™ technology introduces the remarkable Download Cycle feature. This capability allows you to access a wide array of newly developed wash cycles, enhancing the versatility and adaptability of your machine throughout its entire lifespan. Stay up to date with the latest advancements in laundry care, as LG continuously introduces optimized wash cycles tailored to various fabric types and cleaning requirements.
To learn more about LG Washing Machines and Dryers, please visit:
Purchase the Best Washing Machines & Dryers Online | LG UAE
# # #
About LG Electronics Home Appliance & Air Solution Company
The LG Home Appliance & Air Solution Company is a global leader in home appliances, smart home solutions, air solutions as well as visionary products featuring LG ThinQ AI. The company is creating various solutions with its industry leading core technologies and is committed to making life better and healthier for consumers by developing thoughtfully designed kitchen appliances, living appliances, HVAC and air purification solutions. Together, these products deliver enhanced convenience, superb performance, efficient operation and compelling health benefits. For more news on LG, visit www.LGnewsroom.com.
Permalink
https://aetoswire.com/en/news/0806202332745
Contacts
LG-One
Nora Nassar
Email: Nora.Nassar@lg-one.com
BYD Unleashes FANG CHENG BAO, A New Brand that Specializes in Professional and Personalized Identities
(BUSINESS WIRE) -- On June 9, BYD, the world’s leading manufacturer of new energy vehicles, officially announced its new sub-brand FANG CHENG BAO. The brand, as the fifth in the row of the BYD brand matrix, will meet the increasingly personalized needs of consumers by offering a series of unique and professional-grade new energy vehicle models.
FANG CHENG BAO is a significant addition to BYD’s diversified brand matrix, following its Dynasty series, Ocean series, Denza, and Yangwang. The vehicle lineup of FANG CHENG BAO ranges from off-road vehicles to sports cars, and its initial model, a hardcore SUV codenamed SF, is expected to launch this year.
The brand name FANG CHENG BAO translates literally as “Formula” and “Leopard” from Chinese, symbolizing the pursuit of the transformative rise and the exploration of digital realms. It blends the standards and rules of Formula with the agility and wild versatility of the Leopard, bringing out the distinctive essence of the brand and BYD’s vision of future cars and lifestyles.
“Many people think that the global e-mobility transition is a revolution in the automobile industry, where vehicles powered by fossil fuels get replaced by electric cars. However, from BYD, we believe this is only a minor part of the whole transition, and a greater realm is unfolding”, said Wang Chuanfu, Chairman and President of BYD. BYD envisions that FANG CHENG BAO serves as the prelude to the revolution. With an attitude of always staying ahead of trends, FANG CHENG BAO and its users will decode the future of personalized car life through its diverse range of new energy vehicle products.
For press photos, please access the link: https://drive.google.com/drive/folders/1Uu5KU_PdJ6gHsxP_w8skLYSPCFoQ8mXC?usp=sharing
About BYD
BYD is a multinational high-tech company devoted to leveraging technological innovations for a better life. Founded in 1995 as a rechargeable battery maker, BYD now boasts a diverse business scope covering automobiles, rail transit, new energy, and electronics, with over 30 industrial parks in China, the United States, Canada, Japan, Brazil, Hungary, and India. From energy generation and storage to its applications, BYD is dedicated to providing zero-emission energy solutions that reduce global reliance on fossil fuels. Its new energy vehicle footprint now covers 6 continents, over 70 countries and regions, and more than 400 cities. Listed in both Hong Kong and Shenzhen Stock Exchanges, the company is known to be a Fortune Global 500 enterprise that furnishes innovations in pursuit of a greener world.
For more information, please visit www.bydglobal.com.
About BYD Auto
Founded in 2003, BYD Auto is the automotive subsidiary of BYD, a multinational high-tech company devoted to leveraging technological innovations for a better life. Aiming to accelerate the green transition of the global transportation sector, BYD Auto focuses on developing pure electric and plug-in hybrid vehicles. The company has mastered the core technologies of the entire industrial chain of new energy vehicles, such as batteries, electric motors, electronic controllers, and automotive-grade semiconductors. It has witnessed in recent years significant technological advancements, including the Blade Battery, the DM-i and DM-p hybrid technology, the e-Platform 3.0, and the CTB technology. The company is the world’s first carmaker to stop the production of fossil-fueled vehicles on EV shift and has remained top of new energy passenger vehicle sales in China for 9 years in a row.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230608005841/en/
Permalink
https://www.aetoswire.com/en/news/0906202332760
Contacts
Asia-Pacific: Mia Gu, pr@byd.com tel: +86-755-8988-8888-69666
Europe: Penny Peng, PressEU@byd.com tel: +31-102070888
North America: Frank Girardot, frank.girardot@byd.com tel: +1 213 245 6503
Latin America: José Miranda, jose.miranda@byd.com tel: +56 9 96443906
Brazil: Pablo Toledo, pablo.toledo@byd.com tel: +19 3514 2554
Middle East and Africa: Nikki Li, li.namin@byd.com tel: +86-18938862670
Mega Refining and Petrochemical Plant Selects Hytera as Provider of Professional Communications System
(BUSINESS WIRE) -- Hytera, a global leading provider of professional communication technologies and solutions, has been selected as the supplier of professional communications solution for the Yulong Island Refining and Petrochemical Integration Project in Shandong Province, China. Hytera won this public tender with its advanced professional digital trunking (PDT) infrastructure, control and dispatch system, network management system (NMS), digital voice recording system (DVRS), and intrinsically safe (IS) PDT two-way radios.
The Yulong project is the largest refining and petrochemical facility being constructed in China. With a projected overall production capacity of 40 million tons per year, this plant is a strategic venture aimed at driving economic growth, enhancing energy production capabilities, and promoting sustainable development in the region.
This bid awarding is a milestone in the advancement of professional communication technologies within the petrochemical sector of China. Under the agreement, Hytera will deploy an array of cutting-edge systems to enhance the communication and collaboration efficiency among the staff and facilitate safe operations at the Yulong Island Refining and Petrochemical plant.
"The selection of Hytera as the provider for the Yulong Refining and Petrochemical Integration project demonstrates the trust and confidence placed in our cutting-edge PDT communication solutions," said Mu Qiao, the General Manager of Hytera China. "We are proud to contribute to the success of this landmark project, enabling efficient communication and ensuring the safety of personnel across the campus."
About Hytera
Hytera Communications Corporation Limited (SZSE: 002583) is a leading global provider of professional communications technologies and solutions. With voice, video and data capabilities, we provide faster, safer, and more versatile connectivity for business and mission critical users. We make the world more efficient and safer by enabling our customers to achieve more in both daily operations and emergency response. Learn more at https://www.hytera.com/en/home.html.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230609005125/en/
Permalink
https://aetoswire.com/en/news/0906202332764
Contacts
lele.yao@hytera.com
SES Space & Defense Delivers Satellite Connectivity to AWS Modular Data Center for the U.S. Department of Defense
SES Space & Defense to provide Medium Earth Orbit (MEO) and Geostationary Orbit (GEO) services for field-deployed AWS Modular Data Center units and one-hop connectivity to AWS Regions
(BUSINESS WIRE)--SES Space & Defense, a wholly-owned subsidiary of SES, today announced the availability of flexible, secure, and reliable satellite-powered network connectivity for AWS Modular Data Center.
AWS Modular Data Center makes it easy for the U.S. Department of Defense (DoD) to deploy modular data centers managed by Amazon Web Services (AWS) in infrastructure-limited locations. In February 2023, AWS announced the availability of AWS Modular Data Center to the DoD under the Joint Warfighting Cloud Capability (JWCC) contract.
Leveraging SES’s multi-orbit, multi-band global fleet of satellites with AWS Modular Data Center, defense customers can access low-latency, cloud-based applications and services securely in Denied, Disrupted, Intermittent, and Limited (DDIL) environments through a dedicated network connection to AWS Regions. The U.S. DoD customers will also be able to leverage SES’s second-generation medium earth orbit (MEO) constellation, O3b mPOWER, designed with an open architecture approach in space, ground, and user terminal allowing users to bring their own modems/waveform. The introduction of O3b mPOWER system later this year further pushes industry benchmarks, delivering high-performance connectivity services ranging from tens of megabits to multiple gigabits per second for DoD customers.
Leveraging SES’ Cloud Direct offering, SES Space & Defense can enable connectivity between field-deployed AWS Modular Data Center and AWS Regions, allowing one-hop connection between essential cloud services at the tactical edge and a broader set of cloud services in AWS Regions. Customers operating in DDIL environments can utilize SES's satellite connectivity to support temporary AWS Modular Data Center deployments or as an interim connectivity solution for AWS Modular Data Center deployments, enabling customers to deploy workloads immediately upon the delivery of AWS Modular Data Center. Alternatively, if AWS Modular Data Center is utilizing terrestrial connectivity, customers can use SES’s satellite connectivity to provide network redundancy for mission-critical workloads.
President and CEO of SES Space & Defense David Fields said, “Our multi-orbit, multi-band satellite network delivers direct low-latency connectivity to AWS Regions, enabling mission success at the tactical edge. In a network-enabled battlefield, the ability to rapidly and securely extend cloud and edge computing into a tactical ecosystem in real time is critical to our warfighters in theatre.”
Follow us on:
Twitter | Facebook | YouTube | LinkedIn | Instagram
Read our Blogs >
Visit the Media Gallery >
About SES Space & Defense
SES Space & Defense is a wholly-owned subsidiary of SES, the leader in global content connectivity solutions, and is exclusively focused on building, managing, and supporting the most advanced satellite network solutions for the U.S. Government. SES Space & Defense leverages a proven multi-operator network integration and management capability, an extensive global terrestrial network, as well as access to SES’s multi-orbit satellite fleet. It also offers U.S. Department of Defense customers the essential tools in cybersecurity for mission-critical operations, coupled with a proven track record in governance and compliance. SES Space & Defense operates under a proxy board, enabling it to support classified projects, and it has been present in the U.S. Government satcom market for over four decades. Further information can be found at: www.sessd.com.
About SES
SES has a bold vision to deliver amazing experiences everywhere on earth by distributing the highest quality video content and providing seamless connectivity around the world. As the leader in global content connectivity solutions, SES operates the world’s only multi-orbit constellation of satellites with the unique combination of global coverage and high performance, including the commercially-proven, low-latency Medium Earth Orbit O3b system. By leveraging a vast and intelligent, cloud-enabled network, SES is able to deliver high-quality connectivity solutions anywhere on land, at sea or in the air, and is a trusted partner to the world’s leading telecommunications companies, mobile network operators, governments, connectivity and cloud service providers, broadcasters, video platform operators and content owners. SES’s video network carries ~8,000 channels and has an unparalleled reach of 369 million households, delivering managed media services for both linear and non-linear content. The company is listed on Paris and Luxembourg stock exchanges (Ticker: SESG). Further information is available at: www.ses.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230607005952/en/
Permalink
https://www.aetoswire.com/en/news/8062023327388
Contacts
For further information please contact:
Melanie Delannoy
SES Space & Defense
Vice President, Marketing & Communications
Tel. +1 571 443 7993
melanie.delannoy@sessd.com
Verisign Reports Internet Has 354.0 Million Domain Name Registrations at the End of the First Quarter of 2023
RESTON, Va. - Friday, 09. June 2023 AETOSWire Print
(BUSINESS WIRE) -- VeriSign, Inc. (NASDAQ: VRSN), a global provider of domain name registry services and internet infrastructure, today announced that the first quarter of 2023 closed with 354.0 million domain name registrations across all top-level domains (TLDs), an increase of 3.5 million domain name registrations, or 1.0%, compared to the fourth quarter of 2022.1,2 Domain name registrations also increased by 3.5 million, or 1.0%, year over year.1,2
The .com and .net TLDs had a combined total of 174.8 million domain name registrations in the domain name base3 at the end of the first quarter of 2023, an increase of 1.0 million domain name registrations, or 0.6%, compared to the fourth quarter of 2022. The .com and .net TLDs had a combined increase of 0.1 million domain name registrations, or 0.1%, year over year. As of March 31, 2023, the .com domain name base totaled 161.6 million domain name registrations, and the .net domain name base totaled 13.2 million domain name registrations.
New .com and .net domain name registrations totaled 10.3 million at the end of the first quarter of 2023, compared to 10.2 million domain name registrations at the end of the first quarter of 2022.
Total country-code TLD (ccTLD) domain name registrations were 135.7 million at the end of the first quarter of 2023, an increase of 2.6 million domain name registrations, or 2.0%, compared to the fourth quarter of 2022.1,2 ccTLDs increased by 2.3 million domain name registrations, or 1.7%, year over year. The top 10 ccTLDs, as of March 31, 2023, were .cn, .de, .uk, .nl, .ru, .br, .au, .fr, .eu, and .it.1,2 This issue of the Domain Name Industry Brief includes a correction to the March 2023 issue, which incorrectly reported the number of domain name registrations in the .eu ccTLD.2 This was the result of a one-time error in the .eu domain name registration data, provided by ZookNIC, which has since been resolved.
Verisign publishes The Domain Name Industry Brief to provide internet users throughout the world with statistical and analytical research and data on the domain name industry. The Domain Name Industry Brief for the first quarter 2023, as well as previous briefs, can be obtained at Verisign.com/DNIB.
About Verisign
Verisign, a global provider of domain name registry services and internet infrastructure, enables internet navigation for many of the world’s most recognized domain names. Verisign enables the security, stability, and resiliency of key internet infrastructure and services, including providing root zone maintainer services, operating two of the 13 global internet root servers, and providing registration services and authoritative resolution for the .com and .net top-level domains, which support the majority of global e-commerce. To learn more about what it means to be Powered by Verisign, please visit Verisign.com.
VRSN
© 2023 VeriSign, Inc. All rights reserved. VERISIGN, the VERISIGN logo, and other trademarks, service marks, and designs are registered or unregistered trademarks of VeriSign, Inc. and its subsidiaries in the United States and in foreign countries. All other trademarks are property of their respective owners.
1 All figure(s) exclude domain names in the .tk, .cf, .ga, .gq, and .ml ccTLDs. Quarterly and year-over-year trends have been calculated relative to historical figures that have also been adjusted to exclude these five ccTLDs. For further information, please see the Editor’s Note contained in Vol. 19, Issue 1 of The Domain Name Industry Brief.
2 The generic TLD, ngTLD and ccTLD data cited in the brief: (i) includes ccTLD internationalized domain names, (ii) is an estimate as of the time the brief was developed and (iii) is subject to change as more complete data is received. Some numbers in the brief may reflect standard rounding.
3 The domain name base is the active zone plus the number of domain names that are registered but not configured for use in the respective TLD zone file plus the number of domain names that are in a client or server hold status. The .com and .net domain name registration figures are as reported in Verisign’s most recent SEC filings.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230608005751/en/
Permalink
https://www.aetoswire.com/en/news/0906202332756
Contacts
Investor Relations: David Atchley, datchley@verisign.com, + 1 703-948-3447
Media Relations: Dave McGuire, davmcguire@verisign.com, + 1 703-948-3800
Cirium and Aireon Extend Partnership to Offer Live and Historical Aircraft Positional Analytics
LONDON - Thursday, 08. June 2023 AETOSWire
Cirium has blended its industry-leading schedule, fleet, flight status, weather and emissions data with Aireon’s live satellite-based aircraft tracking data for next generation positional analytics and AI
Bringing together these disparate datasets provides situational awareness at a new level of coverage, granularity and accuracy
Empowering airlines, airports and other air transport players to enhance efficiency, reduce operating costs and mitigate passenger disruption
(BUSINESS WIRE) -- Cirium, the aviation analytics company, has extended its long-term agreement with Aireon, the leader in space-based aircraft tracking, to offer live and historical aircraft positional analytics for advanced situational awareness and post-operations analysis.
As Aireon’s selected partner to bring these analytics to market, Cirium is integrating its own industry-leading schedule, fleet, flight status, weather and emissions data with Aireon’s global satellite-based coverage of flight positions to create a fully comprehensive stream of gate-to-gate data.
Aireon’s satellite-based positional data ensures complete coverage of all modern aircraft, equipped with ADS-B, anywhere in the world, including aircraft flying at low altitudes, over oceans or mountainous regions, which cannot be tracked via ground-based receivers.
The enriched level of aircraft positional information will give airlines full visibility across their networks, helping to enhance operational efficiency, reduce fuel burn and mitigate passenger disruption.
“The combination of Aireon’s precise positional data and Cirium’s complete schedule, fleet, flight status and weather data bring unprecedented value to airlines, airports, OEMs, lessors and more that have historically struggled to integrate disparate and incomplete datasets. Insights derived will help to improve the estimated time of arrival (ETA) and flight connection efficiencies, improve delay diagnosis and heighten the intelligence on taxi times,” said Jeremy Bowen, CEO of Cirium.
“We are extremely proud to work with Aireon to deliver premium aircraft positional analytics and provide situational awareness at a level of granularity and accuracy which was previously unavailable.”
“Together, Aireon and Cirium will provide a comprehensive, high fidelity and real-time view of a flight from gate-to-gate. We are delighted to be a part of this growing partnership and to collaborate with Cirium to make complete aircraft positional analytics available across the industry,” said Don Thoma, CEO of Aerion.
After conducting an in-depth market review, Cirium identified Aireon as the key leader in this space with best-in-class end-to-end capabilities across data capture, coverage and quality. This ensures that Cirium is matching the most accurate positional information to the specific ID of the aircraft and the flight number for easier integration into airline and fleet tracking use cases. The data is also fused with critical analytics in Cirium’s Core, including aircraft utilization and flight history data.
Cirium’s real-time and historical aircraft positional analytics will add value for stakeholders throughout the air transport industry, including airlines, airports, aerospace companies, insurers, aircraft lessors and more.
The analytics can be accessed through multiple methods that seamlessly integrate with a business’ existing systems such as a live stream, API, database, and bespoke solutions.
Contact us to find out more. Learn more about Cirium Fleets Analyzer, Schedules and Flight Status solutions.
---ENDS---
Notes to editors
ADS-B is an air traffic surveillance technology and standard that relies on the aircraft broadcasting their identity, a precise GPS position and other information derived from onboard systems.
Unrivalled surveillance data: Aireon’s positional data is the only ATS-grade level surveillance data available today. ATS-grade is the ability to reliably and in real-time detect key flight attributes such as position, level, and intent.
About Cirium
Cirium brings together powerful data and analytics to keep the world moving. Delivering insight, built from decades of experience in the sector, enabling travel companies, aircraft manufacturers, airports, airlines and financial institutions, among others, to make logical and informed decisions which shape the future of travel, growing revenues and enhancing customer experiences. Cirium is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. The shares of RELX PLC are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX.
For further information please follow Cirium updates on LinkedIn or Twitter or visit cirium.com.
About Aireon
Aireon is revolutionizing the global aviation industry with its space-based air traffic surveillance system for Automatic Dependent Surveillance-Broadcast (ADS-B) equipped aircraft. Operational since 2019, Aireon’s ADS-B data network has enabled new levels of operational, safety, and environmental efficiencies for global Air Navigation Service Providers. Now, Aireon is harnessing that next-generation aviation surveillance technologies to bring new data capabilities to the entire aviation industry. To see what Aireon’s data can do for you, visit www.aireon.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230608005493/en/
Permalink
https://www.aetoswire.com/en/news/0806202332750
Contacts
For media enquiries please contact:
Cirium PR: media@cirium.com
The PC Agency (UK and Europe): cirium@pc.agency
Juliett Alpha Media Relations (Americas): cirium@juliettalpha.com
TrainTracks (Japan): cirium@traintracks.jp
Parse Biosciences Launches CRISPR Detect
New product bolsters growing single cell portfolio
(BUSINESS WIRE) -- Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, announced today the launch of CRISPR Detect, enabling single cell pooled CRISPR screens at unprecedented scale.
Bulk pooled CRISPR screening has been a valuable tool to understand gene function on a genome scale. Adding single cell resolution to pooled CRISPR screens pairs individual gene perturbations with rich whole transcriptome expression phenotypes. This approach has expanded the capabilities of pooled CRISPR screening to understand cell types of perturbed cells and quantify changes in gene expression, regulatory networks, signaling pathways, and other complex signatures. However, the applications and scale of these studies have been limited by the throughput and cost of droplet-based single cell RNA-seq technology.
CRISPR Detect brings the scale of existing Parse Evercode technology to single cell CRISPR screening by enabling users to pair perturbations and transcriptional profiles in up to one million cells in a single experiment. This scale will expand the applications of single cell CRISPR screening particularly in drug discovery where cost has limited their use to targeted validation studies.
“We are thrilled to provide CRISPR Detect to the single cell community,” states Charlie Roco, PhD, Chief Technology Officer of Parse Biosciences. “We are particularly excited about the responses from our early access customers around enabling genome scale screens and the potential to expand the usage of single cell CRISPR screening in drug discovery.”
Parse is also announcing the broad availability of UDIs (unique dual indexes) for all Evercode products. UDIs improve sequencing data quality and enable more Evercode sequencing libraries to be analyzed together.
CRISPR Detect and UDIs will be highlighted in an upcoming webinar on June 15 at 9:00 AM PT. For more information, visit https://parse.bio/3IFc8CR.
About Parse Biosciences
Parse Biosciences is a global life sciences company whose mission is to accelerate progress in human health and scientific research. Empowering researchers to perform single cell sequencing with unprecedented scale and ease, its pioneering approach has enabled groundbreaking discoveries in cancer treatment, tissue repair, stem cell therapy, kidney and liver disease, brain development, and the immune system.
With technology developed at The University of Washington by co-founders Alex Rosenberg and Charles Roco, Parse has raised over $50 million in capital and is now used by nearly 1,000 customers across the world. Its growing portfolio of products includes Evercode Whole Transcriptome, Evercode TCR, Gene Capture, and a data analysis solution.
Parse Biosciences is based in Seattle’s vibrant South Lake Union district, where it recently opened a 34,000 square foot headquarters and state-of-the-art laboratory. To learn more, please visit https://www.parsebiosciences.com/.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230608005007/en/
Permalink
https://www.aetoswire.com/en/news/0806202332748
Contacts
Jay Roberts, SRPR
jay@shevrushpr.com | 917.696.2142
Parse Biosciences Launches CRISPR Detect
New product bolsters growing single cell portfolio
(BUSINESS WIRE) -- Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, announced today the launch of CRISPR Detect, enabling single cell pooled CRISPR screens at unprecedented scale.
Bulk pooled CRISPR screening has been a valuable tool to understand gene function on a genome scale. Adding single cell resolution to pooled CRISPR screens pairs individual gene perturbations with rich whole transcriptome expression phenotypes. This approach has expanded the capabilities of pooled CRISPR screening to understand cell types of perturbed cells and quantify changes in gene expression, regulatory networks, signaling pathways, and other complex signatures. However, the applications and scale of these studies have been limited by the throughput and cost of droplet-based single cell RNA-seq technology.
CRISPR Detect brings the scale of existing Parse Evercode technology to single cell CRISPR screening by enabling users to pair perturbations and transcriptional profiles in up to one million cells in a single experiment. This scale will expand the applications of single cell CRISPR screening particularly in drug discovery where cost has limited their use to targeted validation studies.
“We are thrilled to provide CRISPR Detect to the single cell community,” states Charlie Roco, PhD, Chief Technology Officer of Parse Biosciences. “We are particularly excited about the responses from our early access customers around enabling genome scale screens and the potential to expand the usage of single cell CRISPR screening in drug discovery.”
Parse is also announcing the broad availability of UDIs (unique dual indexes) for all Evercode products. UDIs improve sequencing data quality and enable more Evercode sequencing libraries to be analyzed together.
CRISPR Detect and UDIs will be highlighted in an upcoming webinar on June 15 at 9:00 AM PT. For more information, visit https://parse.bio/3IFc8CR.
About Parse Biosciences
Parse Biosciences is a global life sciences company whose mission is to accelerate progress in human health and scientific research. Empowering researchers to perform single cell sequencing with unprecedented scale and ease, its pioneering approach has enabled groundbreaking discoveries in cancer treatment, tissue repair, stem cell therapy, kidney and liver disease, brain development, and the immune system.
With technology developed at The University of Washington by co-founders Alex Rosenberg and Charles Roco, Parse has raised over $50 million in capital and is now used by nearly 1,000 customers across the world. Its growing portfolio of products includes Evercode Whole Transcriptome, Evercode TCR, Gene Capture, and a data analysis solution.
Parse Biosciences is based in Seattle’s vibrant South Lake Union district, where it recently opened a 34,000 square foot headquarters and state-of-the-art laboratory. To learn more, please visit https://www.parsebiosciences.com/.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230608005007/en/
Permalink
https://www.aetoswire.com/en/news/0806202332748
Contacts
Jay Roberts, SRPR
jay@shevrushpr.com | 917.696.2142
Parse Biosciences Launches CRISPR Detect
New product bolsters growing single cell portfolio
(BUSINESS WIRE) -- Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, announced today the launch of CRISPR Detect, enabling single cell pooled CRISPR screens at unprecedented scale.
Bulk pooled CRISPR screening has been a valuable tool to understand gene function on a genome scale. Adding single cell resolution to pooled CRISPR screens pairs individual gene perturbations with rich whole transcriptome expression phenotypes. This approach has expanded the capabilities of pooled CRISPR screening to understand cell types of perturbed cells and quantify changes in gene expression, regulatory networks, signaling pathways, and other complex signatures. However, the applications and scale of these studies have been limited by the throughput and cost of droplet-based single cell RNA-seq technology.
CRISPR Detect brings the scale of existing Parse Evercode technology to single cell CRISPR screening by enabling users to pair perturbations and transcriptional profiles in up to one million cells in a single experiment. This scale will expand the applications of single cell CRISPR screening particularly in drug discovery where cost has limited their use to targeted validation studies.
“We are thrilled to provide CRISPR Detect to the single cell community,” states Charlie Roco, PhD, Chief Technology Officer of Parse Biosciences. “We are particularly excited about the responses from our early access customers around enabling genome scale screens and the potential to expand the usage of single cell CRISPR screening in drug discovery.”
Parse is also announcing the broad availability of UDIs (unique dual indexes) for all Evercode products. UDIs improve sequencing data quality and enable more Evercode sequencing libraries to be analyzed together.
CRISPR Detect and UDIs will be highlighted in an upcoming webinar on June 15 at 9:00 AM PT. For more information, visit https://parse.bio/3IFc8CR.
About Parse Biosciences
Parse Biosciences is a global life sciences company whose mission is to accelerate progress in human health and scientific research. Empowering researchers to perform single cell sequencing with unprecedented scale and ease, its pioneering approach has enabled groundbreaking discoveries in cancer treatment, tissue repair, stem cell therapy, kidney and liver disease, brain development, and the immune system.
With technology developed at The University of Washington by co-founders Alex Rosenberg and Charles Roco, Parse has raised over $50 million in capital and is now used by nearly 1,000 customers across the world. Its growing portfolio of products includes Evercode Whole Transcriptome, Evercode TCR, Gene Capture, and a data analysis solution.
Parse Biosciences is based in Seattle’s vibrant South Lake Union district, where it recently opened a 34,000 square foot headquarters and state-of-the-art laboratory. To learn more, please visit https://www.parsebiosciences.com/.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230608005007/en/
Permalink
https://www.aetoswire.com/en/news/0806202332748
Contacts
Jay Roberts, SRPR
jay@shevrushpr.com | 917.696.2142
Search
Archive
- June 2023 (74)
- May 2023 (224)
- April 2023 (180)
- March 2023 (107)
- February 2023 (124)
- January 2023 (83)
- December 2022 (93)
- November 2022 (142)
- October 2022 (149)
- September 2022 (146)
- August 2022 (111)
- July 2022 (132)
- June 2022 (141)
- May 2022 (151)
- April 2022 (164)
- March 2022 (148)
- February 2022 (80)
- January 2022 (50)
- December 2021 (61)
- November 2021 (82)
- October 2021 (75)
- September 2021 (76)
- August 2021 (76)
- July 2021 (62)
- June 2021 (100)
- May 2021 (100)
- April 2021 (72)
- March 2021 (73)
- February 2021 (61)
- January 2021 (45)
- December 2020 (66)
- November 2020 (59)
- October 2020 (65)
- September 2020 (67)
- August 2020 (54)
- July 2020 (70)
- June 2020 (77)
- May 2020 (60)
- April 2020 (82)
- March 2020 (80)
- February 2020 (47)
- January 2020 (45)
- December 2019 (42)
- November 2019 (9)
Comments
There are currently no blog comments.